Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PK2F | ISIN: CA97111B4047 | Ticker-Symbol: 3D7
Frankfurt
28.03.24
08:00 Uhr
0,061 Euro
-0,001
-0,82 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
WILLOW BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
WILLOW BIOSCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0620,07328.03.
0,0620,07328.03.

Aktuelle News zur WILLOW BIOSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:47Willow Biosciences Reports Fourth Quarter And Fiscal Year 2023 Financials And Operations And Filing Of Its 2023 Aif1
00:42Willow Biosciences Inc (2): Willow loses $13.02-million in 20231
01.03.Willow Biosciences Inc (2): Willow arranges $100,000 (U.S.) placement with Kalsec1
01.03.Willow Biosciences Inc.: Willow Biosciences Announces Second Strategic Investment From Kalsec89CALGARY, AB, Feb. 29, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing...
► Artikel lesen
22.02.Kalsec invests in Willow Biosciences: Funds will be used for development of natural food ingredients1
21.02.Willow Biosciences Inc.: Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food Ingredients95Investment further validates Willow's technology for the development and sustainable manufacture of natural ingredients Additional capital will accelerate commercialization of Willow's pipeline ...
► Artikel lesen
31.01.Willow Biosciences Inc (2): Willow Biosciences to develop API manufacturing process1
16.01.Willow Biosciences Inc (2): Willow Biosciences to work with Enterin on APIs1
10.01.Willow Biosciences Inc (2): Willow Biosciences summarizes 2023 operations1
10.01.Willow Biosciences Inc.: Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023185Estimated FY 2023 revenues in excess of $1.3 million is a record year for the Company Anticipate closing at least three new partnership development agreements including one for our corticosteroid API...
► Artikel lesen
11.12.23Willow Bioscience plans to advance development program with Nasdaq-listed company1
15.11.23Willow Biosciences Inc (2): Willow Biosciences loses $2.23-million in Q34
15.11.23Willow Biosciences Inc.: Willow Biosciences Reports Third Quarter 2023 Financial Results And Provides Corporate Update244Record revenues for the third quarter and the nine months ended September 30, 2023 Patent application filed for a process to produce corticosteroids at an expected significant cost reduction to current...
► Artikel lesen
24.10.23Aurora Cannabis settles patent dispute with Willow Biosciences41
24.10.23Aurora Cannabis Settles Patent Litigation With Willow Biosciences27
24.10.23Aurora Cannabis and Willow Biosciences settle patent litigation21
24.10.23Aurora Cannabis Resolves Patent Litigation With Willow Biosciences25
11.10.23Willow Biosciences Inc (2): Willow Biosciences closes $800,000 debenture financing1
11.10.23WILLOW BIOSCIENCES INC.: WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING1
05.10.23WILLOW BIOSCIENCES INC.: Willow Bioscience teams again with Suanfarma on large volume anti-infective API1
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1